Paclitaxel and Carboplatin Dosing Regimens

Standard NCCN Dosing Regimens for Ovarian Cancer

The National Comprehensive Cancer Network recommends a standard paclitaxel/carboplatin regimen of paclitaxel 175 mg/m² IV over 3 hours followed by carboplatin AUC 5-6 IV over 1 hour on Day 1, repeated every 3 weeks for 6 cycles 1, 2, 3

The National Comprehensive Cancer Network suggests a dose-dense regimen of paclitaxel 80 mg/m² IV over 1 hour on Days 1, 8, and 15 followed by carboplatin AUC 5-6 IV over 1 hour on Day 1, repeated every 3 weeks for 6 cycles 1
The National Comprehensive Cancer Network recommends a weekly regimen of paclitaxel 60 mg/m² IV over 1 hour followed by carboplatin AUC 2 IV over 30 minutes, administered weekly for 18 weeks 1, 4
The National Comprehensive Cancer Network proposes a docetaxel alternative of docetaxel 60-75 mg/m² IV over 1 hour followed by carboplatin AUC 5-6 IV over 1 hour on Day 1, repeated every 3 weeks for 6 cycles 1

Patients with prior platinum exposure have a 27-46% risk of hypersensitivity reactions, particularly after cycle 7, according to Praxis Medical Insights 4
Monitor for hypersensitivity reactions during carboplatin infusion, which occur in 1-30% of patients, as stated by Praxis Medical Insights 4
Reactions typically occur within minutes or during the infusion, as noted by Praxis Medical Insights 4
For patients with mild hypersensitivity or anxiety, premedications and slowed infusion rates may be used without formal desensitization, according to Praxis Medical Insights 4

The NCCN guideline recommends administering paclitaxel 175 mg/m² intravenously over 3 hours before carboplatin (AUC 5–6) given intravenously over 1 hour on Day 1, repeated every 3 weeks for six cycles. This sequence is required to avoid antagonistic drug interactions. 5
For dose‑dense scheduling, the NCCN guideline specifies paclitaxel 80 mg/m² intravenously over 1 hour on Days 1, 8, and 15 followed by carboplatin (AUC 5–6) intravenously over 1 hour on Day 1, repeated every 3 weeks for six cycles. 5
When using docetaxel, the NCCN guideline advises docetaxel 60–75 mg/m² intravenously over 1 hour preceding carboplatin (AUC 5–6) intravenously over 1 hour on Day 1, repeated every 3 weeks for six cycles. 5